Boulder, Colorado, United States The main department of described VC is located in the Boulder. The fund was located in North America if to be more exact in United States.
Besides them, we counted 1 critical employee of this fund in our database.
The common things for fund are deals in the range of 1 - 5 millions dollars. The top amount of exits for fund were in 2011. The important activity for fund was in 2005. The fund is constantly included in less than 2 deals per year.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. Among the most successful fund investment fields, there are Medical, Health Care. Among the various public portfolio startups of the fund, we may underline Taligen Therapeutics
The typical case for the fund is to invest in rounds with 2 participants. The meaningful sponsors for the fund in investment in the same round are High Country Venture. In the next rounds fund is usually obtained by Sanderling Ventures, High Country Venture, Clarus Ventures.
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
OncoVerity | $30M | 22 Aug 2022 | Aurora, Colorado, United States | ||
Taligen Therapeutics | $3M | 01 Aug 2005 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
OncoVerity | $30M | 22 Aug 2022 | Aurora, Colorado, United States | ||
Taligen Therapeutics | $3M | 01 Aug 2005 | Cambridge, Massachusetts, United States |
